INOVIO Pharmaceuticals, Inc.

📍 Plymouth Meeting, United States👥 224 employees💰 Last funded Feb 2023
Biotechnology Research🌐 inovio.com
Website LinkedIn
INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2017–2023 · investors recorded per year
201712020120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in INOVIO Pharmaceuticals, Inc.?
INOVIO Pharmaceuticals, Inc. has 3 investors on record on gritt.io.
When did INOVIO Pharmaceuticals, Inc. last raise funding?
The most recent investment in INOVIO Pharmaceuticals, Inc. recorded on gritt.io was in February 2023.
What industry is INOVIO Pharmaceuticals, Inc. in?
INOVIO Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is INOVIO Pharmaceuticals, Inc. based?
INOVIO Pharmaceuticals, Inc. is headquartered in Plymouth Meeting, United States.